Rising prevalence of infectious diseases is driving the market growth. Increasing demand for point‑of‑care and home testing is fueling the need for lateral flow assays. Technological advancement is improving the efficiency and reliability of the late... Explore Report »
Research Reports in Clinical Diagnostics
Showing 10 results in Clinical Diagnostics
The rising global incidence of sepsis and bloodstream infections increases the demand for accurate and timely diagnostic solutions such as blood culture tests. Growing antibiotic resistance drives the need for precise pathogen identification, fueling... Explore Report »
The growing global incidence of disease is driving demand for timely, accessible diagnostics that enable treatment decisions at the point-of-care. Ongoing advances in technology are improving the accuracy, usability, and efficiency of point-of-care d... Explore Report »
Rising aging population, prone to chronic conditions, propels the demand for in vitro diagnostics. Technological advancements in in vitro diagnostic techniques boost the industry development. The complexity and cost of FDA approval and lack of transp... Explore Report »
Rising global female aging population is increasing demand for menopause therapies. Higher healthcare spending is improving access to hormone treatment services. High therapy cost limits adoption in price-sensitive markets. Growing demand for bioiden... Explore Report »
Advancements in molecular diagnostics enhance the precision and turnaround time of sepsis detection. Compared to older methods, techniques like PCR and NGS allow for faster identification of pathogens. Biomarker-based testing boosts early-stage detec... Explore Report »
Cancer biomarkers are measurable signals within DNA, RNA, or metabolic activity that assist in detecting cancer presence, prognosis level, and guiding and choosing therapy options and monitoring therapy reactions. The market includes tissue tests and... Explore Report »
Global atopic dermatitis clinical trials market size was valued at USD 2.87 billion in 2025. The market is anticipated to grow from USD 3.18 billion in 2026 to USD 7.46 billion by 2034, exhibiting a CAGR of 11.20% during the forecast period. 2025 Mar... Explore Report »
The real-time PCR, digital PCR, and end-point PCR market is witnessing substantial growth due to the emergence of new infectious agents. The constant discovery of novel pathogens has intensified the demand for advanced molecular diagnostic techniques... Explore Report »
The Europe point of care (PoC) diagnostics market size was valued at USD 9.28 billion in 2024, growing at a CAGR of 3.92% from 2025-2034. Key factors driving demand include rising shift towards self-testing, supportive government policies and healthc... Explore Report »